Carol Blecher
Oncology · Elizabeth, NJNPI 1932389368
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.2% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 9.5% — the pattern of someone who eats at a lot of different presentations. Among oncology clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 123 payments — averaging $45.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$535
- Jazz Pharmaceuticals Inc.$470
- Amgen$392
- Johnson & Johnson$359
- AbbVie$350
- GSK$332
- plus $3K from 31 others
What the payments were for
- Food & beverage$5,06790%
- Education$55110%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 10 | $535 |
| Jazz Pharmaceuticals Inc. | 5 | $470 |
| Amgen | 11 | $392 |
| Johnson & Johnson | 8 | $359 |
| AbbVie | 16 | $350 |
| GSK | 4 | $332 |
| Gilead | 3 | $331 |
| Daiichi Sankyo Inc. | 4 | $324 |
| Seagen Inc. | 4 | $225 |
| Astellas Pharma US Inc | 2 | $225 |
| Eisai Inc. | 5 | $199 |
| Bayer | 4 | $198 |
| Novartis | 8 | $174 |
| Sanofi-aventis U.S. LLC | 2 | $172 |
| Bristol Myers Squibb | 2 | $147 |
| Genmab U.S., Inc. | 1 | $125 |
| Sanofi | 4 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $115 |
| Blueprint Medicines Corporation | 1 | $113 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| Foundation Medicine, Inc. | 1 | $98 |
| Pharmacosmos Therapeutics Inc. | 5 | $89 |
| Eagle Pharmaceuticals, Inc. | 1 | $61 |
| Puma Biotechnology, Inc. | 3 | $60 |
| Beigene USA, Inc. | 1 | $35 |
| Stemline Therapeutics Inc. | 2 | $33 |
| Tersera Therapeutics LLC | 2 | $33 |
| Karyopharm Therapeutics Inc. | 1 | $26 |
| Genentech USA, Inc. | 1 | $25 |
| Morphosys, US Inc. | 1 | $23 |
| Incyte Corporation | 1 | $22 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $22 |
| Merck | 1 | $19 |
| Heron Therapeutics, Inc. | 1 | $18 |
| Servier Pharmaceuticals LLC | 1 | $15 |
| Taiho Oncology, Inc. | 1 | $14 |
| G1 Therapeutics, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,617 in reported general payments places this provider in the 90th percentile of 23 oncology providers in New Jersey.
Other oncology in Elizabeth
- Ann McNeillNeptune$372K
- Susan WilsonMarmora$10K
- Wendy VogelLawrenceville$3K
- Deborah SmithRiverdale$2K
- Michelyne GavinCliffside Park$2K
- Amber DelecceSewell$1K
- Jacquelynn WhiteCamden$908
- Mary KellyBerkeley Heights$799
- Dina EspositoWest Orange$620
- Carol BoyerBerkeley Heights$482
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.